1.
Abbas Y, Ihsan N, Adnan A, Moayad M, AlKazzaz A, Maroof A, et al. Iraqi Registry Data Proves Safety and Efficacy of switching to Adalimumab Biosimilar in Treating Rheumatoid Arthritis. Al-Kindy Col. Med. J [Internet]. 2024 Dec. 1 [cited 2025 Jul. 4];20(3):216-21. Available from: https://www.jkmc.uobaghdad.edu.iq/index.php/MEDICAL/article/view/1476